Press Releases

BioreclamationIVT Acquires Biospecimen and Research Services Provider Asterand Bioscience

By Lauren Vagnone | August 10, 2017

Acquisition broadens BioreclamationIVT’s disease-state biospecimen capabilities, particularly in oncology, and expands its scientific service offerings for diagnostic and drug development researchers

Westbury, NY – BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has acquired Asterand Bioscience™, a global provider of high quality, well-characterized human tissue and research solutions with a focus on the oncology market. Asterand Bioscience advances drug research by accelerating target identification and biomarker validation, and improving drug candidate selection to increase the likelihood of clinical success. ”…
Read more

BioreclamationIVT Expands Biological Sample Portfolio to Support Drug, Diagnostic and Vaccine Development for Five Additional Infectious Diseases

By Lauren Vagnone | July 31, 2017

The company now offers HIV-1, HIV-2, dengue, zika and malaria blood-derived biological samples to advance drug, diagnostic and vaccine development against those devastating diseases

Westbury, NY – BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has expanded its infectious disease-state portfolio to include frozen whole blood, plasma and serum samples from patients with HIV-1, HIV-2, dengue, zika and malaria infection. The HIV-1 collection includes samples from pediatric patients and pregnant women.

“We are pleased to be able to provide biopharmaceutical companies with these vitally important biological samples that their researchers need to create diagnostics and develop therapeutic drugs and vaccines against these dreadful diseases. These biological samples are very hard to source because some of the diseases are seen predominantly in donors from underdeveloped countries,” said BioreclamationIVT Senior Vice President, Clinical Operations Clifford M. Raynor. …
Read more

BioreclamationIVT Appoints Vice President of Global Quality and Compliance

By Lauren Vagnone | July 26, 2017

Westbury, NY – BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has appointed Karen Sasse to the newly-created position of vice president of global quality and compliance. Ms. Sasse will be responsible for the company’s quality assurance and quality control activities worldwide.

“We are delighted to have an operations professional of Karen’s caliber join our growing team. Her drive, strong project management skills, and superlative attention to detail will help to ensure that our biological products continue to exceed our customers’ highest expectations,” said BioreclamationIVT Chief Executive Officer Jeff Gatz. …
Read more

BioreclamationIVT and Qualyst Partner to Market Transporter Certified™ Hepatocytes

By Lauren Vagnone | June 22, 2017

Westbury, NY – BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it is partnering with Qualyst Transporter Solutions, LLC (Qualyst) to market Transporter Certified™ cryopreserved human hepatocytes.

Transporter Certified is an industry standard that ensures hepatocytes have physiologic transporter function, metabolic competence and appropriate regulatory pathways under conditions Qualyst has defined. In sandwich culture, the intracellular concentrations in Transporter Certified hepatocytes reflect physiologic conditions because the hepatocytes express functioning uptake and efflux transporters and develop bile pockets similar to bile canaliculi. …
Read more

BioreclamationIVT Signs Exclusive Agreement To Distribute Cellaria Cell Models And Media For Cancer Research

By Lauren Vagnone | April 13, 2017

Westbury, NY – BioreclamationIVT, a leading provider of biospecimens and related services, has signed a new distribution partnership agreement with Cellaria, LLC. According to the terms of the agreement, BioreclamationIVT will have exclusive market and distribution rights to Cellaria’s novel cancer cell lines and cancer culture media in the United States and Canada and non-exclusive rights to sell the products globally. The agreement expands the availability of Cellaria’s offerings to a broader range of potential customers via an established distribution partner with existing relationships inside the biopharmaceutical industry. …
Read more

BioreclamationIVT Acquires TransCell Science

By Lauren Vagnone | March 9, 2017

Westbury, NY  – BioreclamationIVT has acquired TransCell Science, a privately held contract research organization (CRO) specializing in the use of primary cells for phenotypic screening assays.  With its scientific expertise in the areas of cell culture and cell-based assays, clients have looked to TransCell as a partner in developing protocols and conducting studies that provide pertinent data for their research programs.  The output from such studies enables “go” or “no go” decisions with a higher level of confidence at a much earlier time point within the drug discovery process and greatly reduces the chance of downstream failure.

Through prior acquisitions and organic growth, BioreclamationIVT has become the premier supplier of biological specimens to the life sciences industry.  “We have enormous respect for what TransCell Science has accomplished since their founding in 2011,” said Jeff Gatz, BioreclamationIVT CEO.  “Building upon our collective synergies, this transaction positions us to accelerate growth and unleash the full potential of our merged companies.  Together, BioreclamationIVT and TransCell Science will form a complete solution spanning biospecimen acquisition to use of those samples within highly relevant in vitro assays.” …
Read more

ILSBio, LLC merges with BioreclamationIVT

By Lauren Vagnone | July 15, 2015

Westbury, NY – BioreclamationIVT has acquired TransCell Science, a privately held contract research organization (CRO) specializing in the use of primary cells for phenotypic screening assays. With its scientific expertise in the areas of cell culture and cell-based assays, clients have looked to TransCell as a partner in developing protocols and conducting studies that provide pertinent data for their research programs. The output from such studies enables “go” or “no go” decisions with a higher level of confidence at a much earlier time point within the drug discovery process and greatly reduces the chance of downstream failure.

Through prior acquisitions and organic growth, BioreclamationIVT has become the premier supplier of biological specimens to the life sciences industry. “We have enormous respect for what TransCell Science has accomplished since their founding in 2011,” said Jeff Gatz, BioreclamationIVT CEO. “Building upon our collective synergies, this transaction positions us to accelerate growth and unleash the full potential of our merged companies. Together, BioreclamationIVT and TransCell Science will form a complete solution spanning biospecimen acquisition to use of those samples within highly relevant in vitro assays.” …
Read more